$LXRX

$1.51▲ +2.0% YTD

6 SEC 13D/G filings tracked · Last updated Oct 29, 2026

Filing History

News

LXRX ▲ +2.0% - Lexicon Pharmaceuticals, Inc.

CP $1.51▲ +2.0%Oct 29, 2026 · ThinkSabio Blog

$LXRX - Lexicon Pharmaceuticals to Report Third Quarter 2026 Financial Results on November 5, 2026…

News

LXRX ▼ -0.7% - Lexicon Pharmaceuticals, Inc.

CP $1.48▲ -0.7%Oct 23, 2026 · ThinkSabio Blog

$LXRX - Lexicon Pharmaceuticals Provides Update on Baseline Patient Characteristics for Pivotal Phase 3 SONATA-HCM Study of Sotagliflozin in Symptomat…

News

LXRX ▼ -0.6% - Lexicon Pharmaceuticals, Inc.

CP $1.57▲ -0.6%Oct 21, 2026 · ThinkSabio Blog

$LXRX - Lexicon Pharmaceuticals Announces Publication of New Research Highlighting Sotagliflozin’s Biological Effects in Cardiovascular Disease…

News

LXRX ▼ -2.2% - Lexicon Pharmaceuticals, Inc.

CP $2.21▲ -2.2%Sep 1, 2026 · ThinkSabio Blog

$LXRX - Lexicon Pharmaceuticals to Participate at Three Upcoming Investor Conferences…

News

LXRX ▲ +0.4% - Lexicon Pharmaceuticals, Inc.

CP $2.30▲ +0.4%Aug 31, 2026 · ThinkSabio Blog

$LXRX - Lexicon Announces New Post Hoc SOLOIST-WHF Analysis Demonstrating Consistent Sotagliflozin Results Across Baseline Blood Pressure Levels in Pa…

SEC 13D/G

LXRX - Lexicon Pharmaceuticals, Inc. - SEC Filing Update (06-AUG-2026) | ThinkSabio - Stocks Simplified

$2.35▲ 104.35%Aug 6, 2026 · ThinkSabio Blog

$LXRX SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #LXRX Lexicon Pharmaceuticals, Inc. : $2.35 Sector: Healthcare |…